1. Home
  2. CUE vs TONX Comparison

CUE vs TONX Comparison

Compare CUE & TONX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

SELL

Current Price

$21.97

Market Cap

177.0M

Sector

Health Care

ML Signal

SELL

Logo TON Strategy Company

TONX

TON Strategy Company

HOLD

Current Price

$3.31

Market Cap

147.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUE
TONX
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
177.0M
147.6M
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
CUE
TONX
Price
$21.97
$3.31
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $88.00
N/A
AVG Volume (30 Days)
153.2K
★ 177.0K
Earning Date
11-11-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
61.11
★ 69.21
EPS
N/A
★ N/A
Revenue
★ $27,466,000.00
$32,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
195.75
★ 433.33
52 Week Low
$0.17
$1.75
52 Week High
$45.50
$4.44

Technical Indicators

Market Signals
Indicator
CUE
TONX
Relative Strength Index (RSI) 47.86 53.84
Support Level $17.06 $2.85
Resistance Level $33.95 $3.58
Average True Range (ATR) 2.33 0.19
MACD 0.45 0.04
Stochastic Oscillator 41.30 81.87

Price Performance

Historical Comparison
CUE
TONX

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.

About TONX TON Strategy Company

TON Strategy Co is a digital asset treasury and Web3 ecosystem company focused on supporting The Open Network, a public blockchain integrated with Telegram and designed for fast, scalable transactions and decentralized applications. Its core business is managing its holdings of Toncoin (TON), including staking tokens to support network validation and earn rewards, while adhering to regulatory, accounting, and risk management standards. The company also pursues Web3 initiatives to support the ecosystem's growth and adoption. It operates through MARKET. live, Go Fund Yourself, and TON segments, with MARKET.live generating maximum revenue as a multi-vendor livestream shopping platform that combines e-commerce and entertainment across social and video channels.

Share on Social Networks: